Rights and permissions
About this article
Cite this article
ESRD with hyperphosphataemia: an economic burden. Pharmacoecon. Outcomes News 505, 8 (2006). https://doi.org/10.2165/00151234-200605050-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605050-00026